25262 Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Xiaodu Guo, MD, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health 

Room 761, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–4719, 

guox@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Multiethnic Study 

of Type 2 Diabetes Genes. 

Date: July 13, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washingtonian Center Courtyard, 

204 Boardwalk Place, Gaithersburg, MD 

20878. 

Contact Person: Xiaodu Guo, MD, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health 

Room 761, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–4719, 

guox@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; CKD Biomarker 

Discovery and Validation Consortium (U01) 

Date: July 13–14, 2009. 

Time: 5:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Gaithersburg 

Washingtonian Center, 204 Boardwalk Place, 

Gaithersburg, MD 20878. 

Contact Person: Atul Sahai, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

759, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–2242, 

sahaia@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Intestinal Stem 

Cells. 

Date: July 15, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Maria E. Davila-Bloom, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 758, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7637, davilabloomm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: May 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12248 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Conference Grants 1. 

Date: July 1, 2009. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Steven Birken, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, 

National Institutes of Health, 6701 

Democracy Blvd., 10th Fl., Bethesda, MD 

20892, (301) 435–1078, 

birkens@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Recovery Act Limited Competition: 

Extramural Research Facilities Improvement, 

Program 1 (C06). 

Date: July 20–24, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Barbara J. Nelson, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, NIH, 

6701 Democracy Blvd., Room 1080, 1 

Democracy Plaza, Bethesda, MD 20892, (301) 

435–0806. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards, National Institutes of 

Health, HHS) 

Dated: May 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12245 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; ZDE1 VH (31) Review of 

OD–09–058 Competitive Revisions R01 and 

R21 applications. 

Date: June 15, 2009. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Victor Henriquez, PhD, 

Scientific Review Officer, DEA/SRB/NIDCR, 

6701 Democracy Blvd., Room 668, Bethesda, 

MD 20892–4878, 301–451–2405, 

henriquv@nidcr.nih.gov. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; ZDE1 VH (26) Review of 

R03 and R21 Applications on Osteonecrosis 

of the Jaw (ONJ). 

Date: June 22, 2009. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Victor Henriquez, PhD, 

Scientific Review Officer, DEA/SRB/NIDCR, 

6701 Democracy Blvd., Room 668, Bethesda, 

MD 20892–4878, 301–451–2405, 

henriquv@nidcr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 


erowe on PROD1PC63 with NOTICES
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices 25263 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: May 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12234 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group 

(NCIPC IRG) 

Correction: This notice was published 

in the Federal Register on May 1, 2009, 

Volume 74, Number 83, Page 20325. 

The times and place for the 

aforementioned meeting for the review, 

discussion, and evaluation of individual 

research cooperative agreement 

applications submitted in response to 

Fiscal Year 2009 Requests for 

Applications (RFA) related to the 

following individual research 

announcement: RFA EH–09–002 

‘‘Program to Expand State Public Health 

Laboratory Capacity for Newborn 

Bloodspot Screening (U01)’’ has been 

changed to the following: 

Times and Date: 

12:30 p.m.–12:45 p.m., July 9, 2009 (Open) 

12:45 p.m.–2:30 p.m., July 9, 2009 (Closed) 

Place: Teleconference, Toll Free: 888–793– 

2154, Participant Passcode: 4424802. 

Contact Person for More Information: Jane 

Suen, Dr.P.H., M.S., NCIPC, CDC, 4770 

Buford Highway, NE., Mailstop F–62, 

Atlanta, Georgia 30341. Telephone: (770) 

488–4281. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 19, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–12325 Filed 5–26–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group 

(NCIPC IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following teleconference meeting: 

Time and Date: 

2:30 p.m.–2:45 p.m., July 9, 2009 (Open). 

2:45 p.m.–4:30 p.m., July 9, 2009 (Closed). 

Place: Teleconference, Toll Free: 888–793– 

2154, Participant Pass Code: 4424802. 

Status: Portions of the meeting will be 

closed to the public in accordance with 

provisions set forth in section 552b(c)(4) and 

(6), Title 5, U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to section 

10(d) of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and Human 

Services, and the Director, CDC, concerning 

the scientific and technical merit of grant and 

cooperative agreement applications received 

from academic institutions and other public 

and private profit and nonprofit 

organizations, including State and local 

government agencies, to conduct specific 

injury research that focuses on prevention 

and control. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications submitted in 

response to Fiscal Year 2009 Requests for 

Applications (RFA) related to the following 

individual research announcement: RFA EH– 

09–003 ‘‘Program to Enhance State Public 

Health Laboratory Capacity for Newborn 

Bloodspot Screening (U01).’’ 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: Jane 

Suen, Dr.P.H., M.S., NCIPC, CDC, 4770 

Buford Highway, NE., M/S F–62, Atlanta, 

Georgia 30341, Telephone 770–488–4281. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 19, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–12324 Filed 5–26–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Calerie 

Review. 

Date: June 17, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Ramesh Vemuri, PhD, 

Chief, Scientific Review Branch, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 2C– 

212, Bethesda, MD 20892, 301–402–7700, 

rv23r@nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Epidemiology 

of Dementia in an Urban Setting. 

Date: June 24, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C218, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Alfonso R. Latoni, PhD, 

Deputy Chief and Scientific Review Officer, 

Scientific Review Branch, National Institute 

on Aging, Gateway Building, 7201 Wisconsin 

Avenue, Room 2C218, Bethesda, MD 20892, 

301–402–7702, latonia@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Calorie 

Restriction and Effects on IGF. 

Date: June 25, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20814, (Telephone 

Conference Call). 

Contact Person: Bita Nakhai, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 


erowe on PROD1PC63 with NOTICES